Issues related to accelerated approval.
2026 · 2nd Quarter (Apr 1 - June 30)
CLENE NANOMEDICINE
Filed by CAPITOL HILL CONSULTING GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 21, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- CAPITOL HILL CONSULTING GROUP
- Client
- CLENE NANOMEDICINE
- Filing UUID
- 553faa5a-d45b-4b39-978f-70a7f4bb6be5
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.